|
| [March 18, 2013] |
 |
Cross Country Healthcare Reports Fourth Quarter and Full Year 2012 Results
BOCA RATON, Fla. --(Business Wire)--
Cross Country Healthcare, Inc. (Nasdaq: CCRN) today reported results for
the fourth quarter and full year ended December 31, 2012. Current and
historical amounts have been adjusted to reflect the previously
disclosed sale of the Clinical Trial Services segment in February 2013,
which has been reclassified as discontinued operations.
Consolidated revenue from continuing operations for the fourth quarter
of 2012 was $111.7 million, an increase of 3% from the prior year
quarter, but a slight decrease sequentially from the third quarter of
2012. Including discontinued operations, the Company incurred a net loss
in the fourth quarter of 2012 of $9.5 million, or $(0.31) per diluted
share, which includes a non-cash goodwill impairment charge of $(0.24)
per diluted share related to the clinical trial services business. Loss
from continuing operations before income taxes was $1.3 million,
including a $0.8 million charge recognized in the fourth quarter for a
professional liability indemnity claim in the nurse and allied staffing
business. The Company anticipates recovering some, if not all of this
expense in a future period; however, U.S. GAAP accounting rules preclude
the Company from recognizing a gain contingency until it is realized.
The Company also incurred a one-time $0.7 million expense for an
immaterial correction in calculating deferred rent, which primarily
accumulated from 2002 to 2010. Loss from continuing operations after
taxes was $3.0 million, or $(0.10) per diluted share. Cash flow from
operations for the fourth quarter of 2012 was $4.4 million.
In the same quarter of the prior year, the Company had consolidated
revenue from continuing operations of $109.0 million. Loss from
continuing operations in the prior year quarter was $0.2 million. Net
income including discontinued operations was $0.5 million, or $0.02 per
diluted share.
For the full year 2012, consolidated revenue from continuing operations
was $442.6 million, an increase of 1% from the prior year. Including
discontinued operations, the Company had a net loss of $42.2 million, or
$(1.37) per diluted share. The net loss included a non-cash goodwill
impairment charge in the second quarter of 2012 of $12.1 million
after-tax, or $(0.39) per diluted share related to the nurse and allied
staffing business segment, as well as non-cash goodwill and trademark
impairment charges in the third and fourth quarters of 2012 totaling
$24.2 million after-tax, or $(0.79) per diluted share related to the
clinical trial services business segment. Loss from continuing
operations before income taxes was $26.9 million. Loss from continuing
operations was $20.7 million, or $(0.67) per diluted share. Cash flow
from operations for the full year 2012 was $10.1 million.
For the full year 2011, consolidated revenue from continuing operations
was $439.4 million. Income from continuing operations was $1.5 million,
or $0.05 per diluted share. Net income was $4.1 million, or $0.13 per
diluted share, in the prior year.
"While our fourth quarter revenue was in-line with our expectations, our
results were affected by a variety of factors that combined to result in
a loss from continuing operations. Excluding the impact of the
aforementioned professional liability expense, our successful efforts to
improve our gross margin sequentially, primarily in our nurse and allied
staffing segment, delivered results more rapidly than we had expected,"
said Joseph A. Boshart, President and Chief Executive Officer of Cross
Country Healthcare, Inc. "Currently, open orders for our travel nurse
staffing services are significantly above the level of a year ago.
Reflecting the stronger demand environment, bill rates increased in the
fourth quarter, which aided in the expansion of our bill-pay spread," he
stated.
"Our physician staffing business had a strong fourth quarter with
revenue up 10% year-over-year. In our other human capital management
services segment, revenue in our retained search business improved
year-over-year, but it was more than offset by weakness in our education
and training business," said Mr. Boshart.
"Lastly, I would like to thank all of our former clinical trial services
employees for their contributions to Cross Country over the past dozen
years. We wish them every success in the future. Following the sale of
this business, the Company has a debt-free balance sheet and more than
$25 million in cash. Moving forward, we are sharply focused on our
nurse, allied and physician staffing businesses, which we believe have
bright futures given the changing healthcare environment and aging U.S.
population," added Mr. Boshart.
Nurse and Allied Staffing
For the fourth quarter of 2012, the nurse and allied staffing business
segment (travel and per diem nurse and allied health staffing) generated
revenue of $70.9 million, a 1% increase from the prior year quarter and
a 2% increase sequentially from the third quarter of 2012. The increase
in both periods was due entirely to higher bill rates. Contribution
income, defined as (loss) income from operations before depreciation,
amortization, impairment charges and corporate expenses not specifically
identified to a reporting segment, was $4.0 million, a decrease of 27%
year-over-year, but a 36% increase sequentially. The contribution income
margin (defined as a percentage of segment revenue) was 5.7% in the
fourth quarter of 2012, a decrease of 210 basis points year-over-year,
but an increase of 140 basis points sequentially. The year-over-year
decline was primarily due to the aforementioned professional liability
expense along with higher health insurance claims. The sequential
increase was due to lower workers' compensation expenses and expansion
of the bill-pay spread.
Segment staffing volume was essentially flat both year-over-year and
sequentially. Travel staffing volume decreased 1% year-over-year and
decreased slightly sequentially while per diem staffing volume increased
7% year-over-year and 3% sequentially. The average revenue per FTE per
day for the fourth quarter of 2012 was $314, a 1% increase
year-over-year and 2% sequentially. Similarly, the travel nurse staffing
average hourly bill rate increased 2% both year-over-year and
sequentially.
For the full year of 2012, segment revenue decreased slightly to $277.8
million from $278.8 million in the same period a year ago, while
contribution income decreased 41% to $13.2 million from $22.4 million in
the prior year period due primarily to higher health insurance costs and
a decrease in the bill-pay spread as a result of changes in geographic
mix.
Physician Staffing
For the fourth quarter of 2012, the physician staffing business segment
generated revenue of $30.7 million, an increase of 10% from the prior
year quarter, but a 6% decrease sequentially from the third quarter of
2012. The year-over-year increase was due to higher bill rates for most
specialties while the sequential decrease was due to seasonality.
Contribution income was $2.5 million, a 10% decrease year-over-year and
a 21% decrease sequentially. The contribution income margin was 8.0% in
the fourth quarter of 2012, a decrease of 170 basis points from the
prior year quarter and 150 basis points sequentially. The
year-over-year decrease was primarily due to higher professional
liability insurance expenses in the current quarter compared to a
favorable professional liability insurance accrual adjustment in the
prior year quarter partially offset by lower non-income based state
taxes. The sequential decline was due primarily to negative operating
leverage. Physician staffing days filled for the fourth quarter of 2012
was 20,290 days, a slight increase from the prior year quarter, but a
10% decrease sequentially. Revenue per day filled for the fourth quarter
of 2012 was $1,511, up 9% year-over-year and 5% sequentially.
For the full year of 2012, segment revenue increased 4% to $123.5
million from $118.8 million in the same period a year ago, while
contribution income decreased 6% to $10.7 million from $11.3 million in
the prior year period due to higher physician compensation and
professional liability expense partially offset by favorable operating
leverage.
Other Human Capital Management Services
For the fourth quarter of 2012, the other human capital management
services business segment (education and training and retained search)
generated revenue of $10.2 million, a 5% decrease from the prior year
quarter and a 4% increase sequentially from the third quarter of 2012.
The year-over-year decrease was primarily due to lower seminar
attendance in the education and training business partially offset by
higher retainer revenue and placement fees in the physician and
healthcare executive search business while the sequential increase was
due to top-line improvements in both businesses. Contribution income was
$0.5 million, a 37% decrease year-over-year, but a substantial increase
sequentially from $25,000 in the prior quarter. The year-over-year
decrease was due to higher direct mail expenses in the education and
training business offset by a substantial improvement in the retained
search business. Sequentially, both businesses in this segment
experienced improvements.
For the full year of 2012, segment revenue decreased 1% to $41.3 million
from $41.8 million in the same period a year ago, while contribution
income declined 39% to $1.9 million from $3.2 million in the prior year
period.
Debt Outstanding and Credit Facility
At December 31, 2012, the Company had $33.9 million of total debt on its
balance sheet and $10.5 million in cash and cash equivalents. The ratio
of debt, net of cash, to total capitalization was 9.6%.
On January 9, 2013, the Company entered into a Loan and Security
Agreement, by and among the Company and certain of its domestic
subsidiaries, as borrowers, and Bank of America, N.A., as agent. The
Loan Agreement provides for a three-year senior secured asset-based
revolving credit facility in the aggregate principal amount of up to
$65.0 million, which includes a $10.0 million sub-facility for swingline
loans and a $20.0 million sub-facility for standby letters of credit.
The initial proceeds from the revolving credit facility were used to
finance the repayment of the Company's existing indebtedness under its
prior Credit Agreement and the payment of fees and expenses. The new
revolving credit facility will be used to provide ongoing working
capital and for other general corporate purposes of the Company and its
subsidiaries. Additional information related to this Loan and Security
Agreement can be obtained in the Company's Current Report on Form 8-K
dated January 11, 2013.
During February 2013, the Company used a portion of the net proceeds
from the sales of its clinical trial services business to repay
all $29.3 million of its then outstanding bank debt.
Discontinued Operations
In February 2013, the Company sold its clinical trial services business
for $52.0 million, plus an earn-out of up to $3.75 million related to
certain performance-based milestones. Accordingly, this business is
being accounted for as discontinued operations. For the fourth quarter
of 2012, loss from discontinued operations was $6.5 million after-tax,
or $(0.21) per diluted share, and included a non-cash goodwill
impairment charge in the fourth quarter of 2012 of $7.3 million
after-tax, or $(0.24) per diluted share.
Guidance for First Quarter 2013
The following statements are based on current management expectations.
Such statements are forward-looking and actual results may differ
materially. These statements do not include the potential impact of any
future mergers, acquisitions or other business combinations, any
impairment charges or valuation allowances, or significant legal
proceedings. For the first quarter of 2013, the Company expects:
-
Revenue to be in the $110.0 million to $112.0 million range.
-
Gross profit margin to be in the 24.5% to 25.0% range.
-
Adjusted EBITDA from continuing operations margin to be in the 0.0% to
2.0% range. Adjusted EBITDA, a non-GAAP financial measure, is defined
in the accompanying financial statement tables.
-
Earnings per diluted share to be essentially at break-even.
Quarterly Conference Call
The Company will hold its quarterly conference call on Monday, March 18,
2013, at 5:00 p.m. Eastern Time to discuss its fourth quarter and full
year 2012 financial results. The call will be webcast live and can be
accessed online at www.crosscountryhealthcare.com
or by dialing 888-972-6408 in the U.S. or 210-234-0087 from non-U.S.
locations - Passcode: Cross Country. From March 18th through April 1st,
a replay of the webcast will be available at the Company's website and a
replay of the conference call will be available via telephone by calling
888-662-6650 in the U.S. or 402-220-6416 from non-U.S. locations -
Passcode: 2012.
Non-GAAP (Generally Accepted Accounting Principles) Financial Measures
This press release and accompanying financial statement tables reference
non-GAAP financial measures. Such non-GAAP financial measures are
provided as additional information and should not be considered
substitutes for, or superior to, financial measures calculated in
accordance with U.S. GAAP. Such non-GAAP financial measures are provided
for consistency and comparability to prior year results; furthermore,
management believes they are useful to investors when evaluating the
Company's performance as it excludes certain items that management
believes are not indicative of the Company's operating performance. Such
non-GAAP financial measures may differ materially from the non-GAAP
financial measures used by other companies. The financial statement
tables that accompany this press release include a reconciliation of
each non-GAAP financial measure to the most directly comparable U.S.
GAAP financial measure and a more detailed discussion of each financial
measure; as such, the financial statement tables should be read in
conjunction with the presentation of these non-GAAP financial measures.
About Cross Country Healthcare
Cross Country Healthcare, Inc. is a leader in healthcare staffing with a
primary focus on providing nurse, allied and physician (locum tenens)
staffing services and workforce solutions to the healthcare market. The
Company believes it is one of the top two providers of nurse and allied
staffing services, one of the top four providers of temporary physician
staffing services, and one of the top five providers of retained
physician and healthcare executive search services. The Company also is
a leading provider of education and training programs specifically for
the healthcare marketplace. On a company-wide basis, Cross Country
Healthcare has approximately 4,000 contracts with hospitals and
healthcare facilities, and other healthcare organizations to provide our
staffing services and workforce solutions. Copies of this and other news
releases as well as additional information about Cross Country
Healthcare can be obtained online at www.crosscountryhealthcare.com.
Shareholders and prospective investors can also register to
automatically receive the Company's press releases, SEC filings and
other notices by e-mail.
In addition to historical information, this press release contains
statements relating to our future results (including certain projections
and business trends) that are "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"), and are subject to the "safe harbor" created by those
sections. Forward-looking statements consist of statements that are
predictive in nature, depend upon or refer to future events. Words such
as "expects", "anticipates", "intends", "plans", "believes",
"estimates", "suggests", "appears", "seeks", "will" and variations of
such words and similar expressions intended to identify forward-looking
statements. Forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause our actual results and
performance to be materially different from any future results or
performance expressed or implied by these forward-looking statements.
These factors include, without limitation, the following: our ability to
attract and retain qualified nurses, physicians and other healthcare
personnel, costs and availability of short-term housing for our travel
nurses and physicians, demand for the healthcare services we provide,
both nationally and in the regions in which we operate, the functioning
of our information systems, the effect of existing or future government
regulation and federal and state legislative and enforcement initiatives
on our business, our clients' ability to pay us for our services, our
ability to successfully implement our acquisition and development
strategies, the effect of liabilities and other claims asserted against
us, the effect of competition in the markets we serve, our ability to
successfully defend the Company, its subsidiaries, and its officers and
directors on the merits of any lawsuit or determine its potential
liability, if any, and other factors set forth in Item 1A. "Risk
Factors" in the Company's Annual Report on Form 10-K for the year ended
December 31, 2011, and our other Securities and Exchange Commission
filings made prior to the date hereof.
Although we believe that these statements are based upon reasonable
assumptions, we cannot guarantee future results and readers are
cautioned not to place undue reliance on these forward-looking
statements, which reflect management's opinions only as of the date of
this press release. There can be no assurance that (i) we have correctly
measured or identified all of the factors affecting our business or the
extent of these factors' likely impact, (ii) the available information
with respect to these factors on which such analysis is based is
complete or accurate, (iii) such analysis is correct or (iv) our
strategy, which is based in part on this analysis, will be successful.
The Company undertakes no obligation to update or revise forward-looking
statements. All references to "we," "us," "our," or "Cross Country" in
this press release mean Cross Country Healthcare, Inc., its subsidiaries
and affiliates.
|
|
|
Cross Country Healthcare, Inc.
|
|
Consolidated Statements of Operations
|
|
(Unaudited, amounts in thousands, except per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Year Ended
|
|
|
|
December 31,
|
|
December 31,
|
|
September 30,
|
|
December 31,
|
|
December 31,
|
|
|
|
2012
|
|
2011
|
|
2012
|
|
2012
|
|
2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue from services
|
|
$
|
111,731
|
|
|
$
|
108,991
|
|
|
$
|
112,257
|
|
$
|
442,635
|
|
$
|
439,377
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
Direct operating expenses
|
|
|
83,787
|
|
|
|
78,840
|
|
|
|
84,802
|
|
|
331,050
|
|
|
319,989
|
|
Selling, general and administrative expenses
|
|
|
27,055
|
|
|
|
26,155
|
|
|
|
26,832
|
|
|
109,417
|
|
|
104,544
|
|
Bad debt expense
|
|
|
195
|
|
|
|
329
|
|
|
|
268
|
|
|
786
|
|
|
574
|
|
Depreciation (c)
|
|
|
1,107
|
|
|
|
1,395
|
|
|
|
1,035
|
|
|
4,905
|
|
|
5,965
|
|
Amortization (c)
|
|
|
566
|
|
|
|
566
|
|
|
|
566
|
|
|
2,263
|
|
|
2,394
|
|
Impairment charges (a)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
18,732
|
|
|
-
|
|
Total operating expenses
|
|
|
112,710
|
|
|
|
107,285
|
|
|
|
113,503
|
|
|
467,153
|
|
|
433,466
|
|
(Loss) income from operations
|
|
|
(979
|
)
|
|
|
1,706
|
|
|
|
(1,246)
|
|
|
(24,518)
|
|
|
5,911
|
|
Other (income) expenses:
|
|
|
|
|
|
|
|
|
|
|
|
Foreign exchange (income) loss
|
|
|
(65
|
)
|
|
|
(124
|
)
|
|
|
108
|
|
|
(62)
|
|
|
(264)
|
|
Interest expense, net
|
|
|
433
|
|
|
|
676
|
|
|
|
697
|
|
|
2,341
|
|
|
2,856
|
|
Loss on modification of debt
|
|
|
-
|
|
|
|
-
|
|
|
|
82
|
|
|
82
|
|
|
-
|
|
Other (income) expense, net
|
|
|
(23
|
)
|
|
|
(70
|
)
|
|
|
(89)
|
|
|
16
|
|
|
(298)
|
|
(Loss) income from continuing operations before income taxes
|
|
|
(1,324
|
)
|
|
|
1,224
|
|
|
|
(2,044)
|
|
|
(26,895)
|
|
|
3,617
|
|
Income tax expense (benefit)
|
|
|
1,661
|
|
|
|
1,416
|
|
|
|
(2,763)
|
|
|
(6,150)
|
|
|
2,069
|
|
(Loss) income from continuing operations
|
|
|
(2,985
|
)
|
|
|
(192
|
)
|
|
|
719
|
|
|
(20,745)
|
|
|
1,548
|
|
Discontinued operations, net of income taxes (b)
|
|
|
(6,548
|
)
|
|
|
724
|
|
|
|
(18,319)
|
|
|
(21,476)
|
|
|
2,550
|
|
Net (loss) income
|
|
$
|
(9,533
|
)
|
|
$
|
532
|
|
|
$
|
(17,600)
|
|
$
|
(42,221)
|
|
$
|
4,098
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income per common share, basic:
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income from continuing operations
|
|
$
|
(0.10
|
)
|
|
$
|
0.00
|
|
|
$
|
0.02
|
|
$
|
(0.67)
|
|
$
|
0.05
|
|
Discontinued operations (b)
|
|
|
(0.21
|
)
|
|
|
0.02
|
|
|
|
(0.59)
|
|
|
(0.70)
|
|
|
0.08
|
|
Net (loss) income
|
|
$
|
(0.31
|
)
|
|
$
|
0.02
|
|
|
$
|
(0.57)
|
|
$
|
(1.37)
|
|
$
|
0.13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income per common share, diluted:
|
|
|
|
|
|
|
|
|
|
|
(Loss) income from continuing operations
|
|
$
|
(0.10
|
)
|
|
$
|
0.00
|
|
|
$
|
0.02
|
|
$
|
(0.67)
|
|
$
|
0.05
|
|
Discontinued operations (b)
|
|
|
(0.21
|
)
|
|
|
0.02
|
|
|
|
(0.59)
|
|
|
(0.70)
|
|
|
0.08
|
|
Net (loss) income
|
|
$
|
(0.31
|
)
|
|
$
|
0.02
|
|
|
$
|
(0.57)
|
|
$
|
(1.37)
|
|
$
|
0.13
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
30,902
|
|
|
|
31,108
|
|
|
|
30,902
|
|
|
30,843
|
|
|
31,146
|
|
Diluted
|
|
|
30,902
|
|
|
|
31,117
|
|
|
|
30,902
|
|
|
30,843
|
|
|
31,192
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cross Country Healthcare, Inc.
|
|
Reconciliation of Non-GAAP Financial Measures
|
|
Adjusted EBITDA (d)
|
|
(Unaudited, amounts in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Year Ended
|
|
|
|
December 31,
|
|
December 31,
|
|
September 30,
|
|
December 31,
|
|
December 31,
|
|
|
|
2012
|
|
2011
|
|
2012
|
|
2012
|
|
2011
|
|
(Loss) income from operations
|
|
$
|
(979
|
)
|
|
$
|
1,706
|
|
|
$
|
(1,246)
|
|
$
|
(24,518)
|
|
$
|
5,911
|
|
Depreciation (c)
|
|
|
1,107
|
|
|
|
1,395
|
|
|
|
1,035
|
|
|
4,905
|
|
|
5,965
|
|
Amortization (c)
|
|
|
566
|
|
|
|
566
|
|
|
|
566
|
|
|
2,263
|
|
|
2,394
|
|
Impairment charges (a)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
18,732
|
|
|
-
|
|
Equity compensation
|
|
|
615
|
|
|
|
645
|
|
|
|
611
|
|
|
2,595
|
|
|
2,895
|
|
Adjusted EBITDA from continuing operations
|
|
|
1,309
|
|
|
|
4,312
|
|
|
|
966
|
|
|
3,977
|
|
|
17,165
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA from discontinued operations
|
|
|
1,905
|
|
|
|
1,473
|
|
|
|
1,574
|
|
|
6,363
|
|
|
6,555
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA (d)
|
|
$
|
3,214
|
|
|
$
|
5,785
|
|
|
$
|
2,540
|
|
$
|
10,340
|
|
$
|
23,720
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cross Country Healthcare, Inc.
|
|
Condensed Consolidated Balance Sheets (e)
|
|
(Unaudited, amounts in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
December 31,
|
|
|
|
|
|
|
|
|
|
2012
|
|
2011
|
|
|
|
|
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
10,463
|
|
|
$
|
10,648
|
|
|
|
|
|
|
|
|
Short-term cash investments
|
|
|
-
|
|
|
|
1,691
|
|
|
|
|
|
|
|
|
Accounts receivable, net
|
|
|
62,674
|
|
|
|
71,802
|
|
|
|
|
|
|
|
|
Deferred tax assets
|
|
|
12,561
|
|
|
|
10,645
|
|
|
|
|
|
|
|
|
Income taxes receivable
|
|
|
586
|
|
|
|
1,879
|
|
|
|
|
|
|
|
|
Prepaid expenses
|
|
|
5,580
|
|
|
|
7,441
|
|
|
|
|
|
|
|
|
Assets held for sale
|
|
|
46,971
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Insurance recovery receivable
|
|
|
5,484
|
|
|
|
4,741
|
|
|
|
|
|
|
|
|
Other current assets
|
|
|
1,049
|
|
|
|
701
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
145,368
|
|
|
|
109,548
|
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
|
8,235
|
|
|
|
12,018
|
|
|
|
|
|
|
|
|
Trademarks, net
|
|
|
48,701
|
|
|
|
52,053
|
|
|
|
|
|
|
|
|
Goodwill, net
|
|
|
62,712
|
|
|
|
143,344
|
|
|
|
|
|
|
|
|
Other identifiable intangible assets, net
|
|
|
14,492
|
|
|
|
21,195
|
|
|
|
|
|
|
|
|
Debt issuance costs, net (e)
|
|
|
1,610
|
|
|
|
1,199
|
|
|
|
|
|
|
|
|
Non-current deferred tax assets
|
|
|
16,182
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Other long-term assets
|
|
|
8,623
|
|
|
|
8,585
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
305,923
|
|
|
$
|
347,942
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and Stockholders' Equity
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable and accrued expenses
|
|
$
|
10,130
|
|
|
$
|
9,018
|
|
|
|
|
|
|
|
|
Accrued employee compensation and benefits
|
|
|
21,650
|
|
|
|
21,074
|
|
|
|
|
|
|
|
|
Current portion of long-term debt
|
|
|
33,683
|
|
|
|
16,998
|
|
|
|
|
|
|
|
|
Liabilities related to assets held for sale
|
|
|
2,835
|
|
|
|
-
|
|
|
|
|
|
|
|
|
Other current liabilities
|
|
|
4,289
|
|
|
|
4,002
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
72,587
|
|
|
|
51,092
|
|
|
|
|
|
|
|
|
Long-term debt
|
|
|
176
|
|
|
|
25,048
|
|
|
|
|
|
|
|
|
Non-current deferred tax liabilities
|
|
|
-
|
|
|
|
58
|
|
|
|
|
|
|
|
|
Other long-term liabilities
|
|
|
24,038
|
|
|
|
22,444
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
$
|
96,801
|
|
|
$
|
98,642
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' equity:
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
|
3
|
|
|
|
3
|
|
|
|
|
|
|
|
|
Additional paid-in capital
|
|
|
244,924
|
|
|
|
243,170
|
|
|
|
|
|
|
|
|
Accumulated other comprehensive loss
|
|
|
(3,083
|
)
|
|
|
(3,373
|
)
|
|
|
|
|
|
|
|
(Accumulated deficit) retained earnings
|
|
|
(32,722
|
)
|
|
|
9,500
|
|
|
|
|
|
|
|
|
Total stockholders' equity
|
|
$
|
209,122
|
|
|
$
|
249,300
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders' equity
|
|
$
|
305,923
|
|
|
$
|
347,942
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cross Country Healthcare, Inc.
|
|
Segment Data (f)
|
|
(Unaudited, amounts in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
|
|
|
|
December 31,
|
|
December 31,
|
|
September 30,
|
|
YOY
|
|
Sequential
|
|
|
|
2012
|
|
2011
|
|
2012
|
|
% change
|
|
|
% change
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue from services:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nurse and allied staffing
|
|
$
|
70,850
|
|
|
$
|
70,287
|
|
|
$
|
69,750
|
|
|
1%
|
|
|
2%
|
|
Physician staffing
|
|
|
30,667
|
|
|
|
27,928
|
|
|
|
32,680
|
|
|
10%
|
|
|
-6%
|
|
Other human capital management services
|
|
|
10,214
|
|
|
|
10,776
|
|
|
|
9,827
|
|
|
-5%
|
|
|
4%
|
|
|
|
$
|
111,731
|
|
|
$
|
108,991
|
|
|
$
|
112,257
|
|
|
3%
|
|
|
0%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contribution income (g)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nurse and allied staffing
|
|
$
|
4,012
|
|
|
$
|
5,473
|
|
|
$
|
2,950
|
|
|
-27%
|
|
|
36%
|
|
Physician staffing
|
|
|
2,460
|
|
|
|
2,720
|
|
|
|
3,108
|
|
|
-10%
|
|
|
-21%
|
|
Other human capital management services
|
|
|
534
|
|
|
|
852
|
|
|
|
25
|
|
|
-37%
|
|
|
2036%
|
|
|
|
$
|
7,006
|
|
|
$
|
9,045
|
|
|
$
|
6,083
|
|
|
-23%
|
|
|
15%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unallocated corporate overhead
|
|
$
|
6,312
|
|
|
$
|
5,378
|
|
|
$
|
5,728
|
|
|
-17%
|
|
|
-10%
|
|
Depreciation (c)
|
|
|
1,107
|
|
|
|
1,395
|
|
|
|
1,035
|
|
|
21%
|
|
|
-7%
|
|
Amortization (c)
|
|
|
566
|
|
|
|
566
|
|
|
|
566
|
|
|
0%
|
|
|
0%
|
|
(Loss) income from operations
|
|
$
|
(979
|
)
|
|
$
|
1,706
|
|
|
$
|
(1,246)
|
|
|
-157%
|
|
|
21%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
December 31,
|
|
YOY
|
|
|
|
|
|
|
|
2012
|
|
2011
|
|
% change
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue from services:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nurse and allied staffing
|
|
$
|
277,754
|
|
|
$
|
278,793
|
|
|
|
0%
|
|
|
|
|
|
Physician staffing
|
|
|
123,545
|
|
|
|
118,781
|
|
|
|
4%
|
|
|
|
|
|
Other human capital management services
|
|
|
41,336
|
|
|
|
41,803
|
|
|
|
-1%
|
|
|
|
|
|
|
|
$
|
442,635
|
|
|
$
|
439,377
|
|
|
|
1%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contribution income (g)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nurse and allied staffing
|
|
$
|
13,202
|
|
|
$
|
22,441
|
|
|
|
-41%
|
|
|
|
|
|
Physician staffing
|
|
|
10,652
|
|
|
|
11,320
|
|
|
|
-6%
|
|
|
|
|
|
Other human capital management services
|
|
|
1,944
|
|
|
|
3,172
|
|
|
|
-39%
|
|
|
|
|
|
|
|
$
|
25,798
|
|
|
$
|
36,933
|
|
|
|
-30%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unallocated corporate overhead
|
|
$
|
24,416
|
|
|
$
|
22,663
|
|
|
|
-8%
|
|
|
|
|
|
Depreciation (c)
|
|
|
4,905
|
|
|
|
5,965
|
|
|
|
18%
|
|
|
|
|
|
Amortization (c)
|
|
|
2,263
|
|
|
|
2,394
|
|
|
|
5%
|
|
|
|
|
|
Impairment charges (a)
|
|
|
18,732
|
|
|
|
-
|
|
|
|
-100%
|
|
|
|
|
|
(Loss) income from operations
|
|
$
|
(24,518
|
)
|
|
$
|
5,911
|
|
|
|
-515%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cross Country Healthcare, Inc.
|
|
Other Financial Data
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Year Ended
|
|
|
|
December 31,
|
|
December 31,
|
|
September 30,
|
|
December 31,
|
|
December 31,
|
|
|
|
2012
|
|
2011
|
|
2012
|
|
2012
|
|
2011
|
|
Net cash provided by operating activities (in thousands)
|
|
$
|
4,440
|
|
|
$
|
3,666
|
|
|
$
|
1,903
|
|
$
|
10,146
|
|
$
|
18,296
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nurse and allied staffing statistical data:
|
|
|
|
|
|
|
|
|
|
|
|
FTEs (h)
|
|
|
2,452
|
|
|
|
2,457
|
|
|
|
2,450
|
|
|
2,446
|
|
|
2,472
|
|
Days worked (i)
|
|
|
225,584
|
|
|
|
226,044
|
|
|
|
225,400
|
|
|
895,236
|
|
|
902,280
|
|
Average nurse and allied staffing revenue per FTE per day (j)
|
|
$
|
314
|
|
|
$
|
311
|
|
|
$
|
309
|
|
$
|
310
|
|
$
|
309
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Physician staffing statistical data:
|
|
|
|
|
|
|
|
|
|
|
|
Days filled (k)
|
|
|
20,290
|
|
|
|
20,200
|
|
|
|
22,647
|
|
|
85,001
|
|
|
85,416
|
|
Revenue per days filled (l)
|
|
$
|
1,511
|
|
|
$
|
1,383
|
|
|
$
|
1,443
|
|
$
|
1,453
|
|
$
|
1,391
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) Impairment charges relate to the impairment of goodwill in the
Company's nurse and allied staffing reporting unit pursuant to the Intangibles-Goodwill
and Other Topic of the Financial Accounting Standards Board
(FASB) Accounting Standards Codification (ASC) No. 350.
|
|
(b) Discontinued operations include the results of the Company's
clinical trial services business segment which include the
impairment of its goodwill and certain trademarks in its third and
fourth quarters of 2012. In the fourth quarter of 2012, the
Company decided to sell this business segment and completed the
sale on February 15, 2013.
|
|
(c) Excludes depreciation and amortization of discontinued
operations. Total depreciation and amortization included in
discontinued operations were (in thousands): 1Q12-$447, 2Q12-$447,
3Q12-$422, 4Q12-$464, 1Q11-$534, 2Q11-$467, 3Q11-$470 and 4Q11-$455.
|
|
(d) Adjusted EBITDA, a non-GAAP (Generally Accepted Accounting
Principles) financial measure, is defined as (loss) income from
operations before depreciation, amortization, impairment charges and
non-cash equity compensation. Adjusted EBITDA should not be
considered a measure of financial performance under GAAP. Management
presents Adjusted EBITDA because it believes that Adjusted EBITDA is
a useful supplement to (loss) income from operations as an indicator
of operating performance. Management uses Adjusted EBITDA as one
performance measure in its annual cash incentive program for certain
members of its management team. In addition, management monitors
Adjusted EBITDA for planning purposes, including compliance with its
debt covenants. Adjusted EBITDA, as defined, closely matches the
operating measure typically used in the Company's credit facilities
in calculating various ratios. Management believes Adjusted EBITDA,
as defined, is useful to investors when evaluating the Company's
performance as it excludes certain items that management believes
are not indicative of the Company's operating performance. Adjusted
EBITDA Margin is calculated by dividing Adjusted EBITDA by the
Company's consolidated revenue.
|
|
(e) Certain prior year amounts have been reclassified to conform to
the current period's presentation.
|
|
(f) Segment data provided is in accordance with the Segment
Reporting Topic of the FASB ASC.
|
|
(g) Defined as (loss) income from operations before depreciation,
amortization, impairment charges and corporate expenses not
specifically identified to a reporting segment. Contribution income
is a financial measure used by management when assessing segment
performance.
|
|
(h) FTEs represent the average number of nurse and allied contract
staffing personnel on a full-time equivalent basis.
|
|
(i) Days worked is calculated by multiplying the FTEs by the number
of days during the respective period.
|
|
(j) Average revenue per FTE per day is calculated by dividing the
nurse and allied staffing revenue by the number of days worked in
the respective periods. Nurse and allied staffing revenue also
includes revenue from permanent placement of nurses.
|
|
(k) Days filled is calculated by dividing the total hours filled
during the period by 8 hours.
|
|
(l) Revenue per day filled is calculated by dividing the applicable
revenue generated by the Company's physician staffing segment by
days filled for the period presented.
|

[ Back To Insurance Technology's Homepage ]
|